Furthermore, among the mice treated with the combination therapy, levels of Th1 cytokine IFNγ and T-cell-recruiting chemokine CCL5 in the tumor were significantly lower in the B cell KO mice than in the WT mice, whereas the level of VEGF was significantly higher in the B cell KO mice (Figure 2D). The gene discussed is CCL5; the disease is neoplasm.